250 related articles for article (PubMed ID: 19124644)
1. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein.
López-Gallardo E; Solano A; Herrero-Martín MD; Martínez-Romero I; Castaño-Pérez MD; Andreu AL; Herrera A; López-Pérez MJ; Ruiz-Pesini E; Montoya J
J Med Genet; 2009 Jan; 46(1):64-7. PubMed ID: 19124644
[TBL] [Abstract][Full Text] [Related]
2. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
[TBL] [Abstract][Full Text] [Related]
3. Stability of the m.8993T->G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome.
Steffann J; Gigarel N; Corcos J; Bonnière M; Encha-Razavi F; Sinico M; Prevot S; Dumez Y; Yamgnane A; Frydman R; Munnich A; Bonnefont JP
J Med Genet; 2007 Oct; 44(10):664-9. PubMed ID: 17545557
[TBL] [Abstract][Full Text] [Related]
4. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].
Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J
Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959
[TBL] [Abstract][Full Text] [Related]
5. Novel genetic and neuropathological insights in neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP).
Claeys KG; Abicht A; Häusler M; Kleinle S; Wiesmann M; Schulz JB; Horvath R; Weis J
Muscle Nerve; 2016 Aug; 54(2):328-33. PubMed ID: 27015314
[TBL] [Abstract][Full Text] [Related]
6. A novel mitochondrial mutation m.8989G>C associated with neuropathy, ataxia, retinitis pigmentosa - the NARP syndrome.
Duno M; Wibrand F; Baggesen K; Rosenberg T; Kjaer N; Frederiksen AL
Gene; 2013 Feb; 515(2):372-5. PubMed ID: 23266623
[TBL] [Abstract][Full Text] [Related]
7. [Leigh syndrome resulting from a de novo mitochondrial DNA mutation (T8993G)].
Playán A; Solano-Palacios A; González de la Rosa JB; Merino-Arribas JM; Andreu AL; López-Pérez M; Montoya J
Rev Neurol; 2002 Jun 16-30; 34(12):1124-6. PubMed ID: 12134275
[TBL] [Abstract][Full Text] [Related]
8. A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome.
Mordel P; Schaeffer S; Dupas Q; Laville MA; Gérard M; Chapon F; Allouche S
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):133-137. PubMed ID: 29054413
[TBL] [Abstract][Full Text] [Related]
9. Unusual findings in Leigh syndrome caused by T8993C mutation.
Yiş U; Seneca S; Dirik E; Kurul SH; Ozer E; Cakmakçi H; De Meirleir L
Eur J Paediatr Neurol; 2009 Nov; 13(6):550-2. PubMed ID: 19046652
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T-->C mutation.
Rantamäki MT; Soini HK; Finnilä SM; Majamaa K; Udd B
Ann Neurol; 2005 Aug; 58(2):337-40. PubMed ID: 16049925
[TBL] [Abstract][Full Text] [Related]
11. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
[TBL] [Abstract][Full Text] [Related]
12. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
[TBL] [Abstract][Full Text] [Related]
13. Identification and biochemical characterization of the novel mutation m.8839G>C in the mitochondrial ATP6 gene associated with NARP syndrome.
Blanco-Grau A; Bonaventura-Ibars I; Coll-Cantí J; Melià MJ; Martinez R; Martínez-Gallo M; Andreu AL; Pinós T; García-Arumí E
Genes Brain Behav; 2013 Nov; 12(8):812-20. PubMed ID: 24118886
[TBL] [Abstract][Full Text] [Related]
14. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load.
Enns GM; Bai RK; Beck AE; Wong LJ
Mol Genet Metab; 2006 Aug; 88(4):364-71. PubMed ID: 16546428
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.
Kytövuori L; Lipponen J; Rusanen H; Komulainen T; Martikainen MH; Majamaa K
J Neurol; 2016 Nov; 263(11):2188-2195. PubMed ID: 27502083
[TBL] [Abstract][Full Text] [Related]
16. CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations.
Fujita Y; Ito M; Nozawa Y; Yoneda M; Oshida Y; Tanaka M
Mitochondrion; 2007; 7(1-2):80-8. PubMed ID: 17276738
[TBL] [Abstract][Full Text] [Related]
17. Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA.
White SL; Shanske S; Biros I; Warwick L; Dahl HM; Thorburn DR; Di Mauro S
Prenat Diagn; 1999 Dec; 19(12):1165-8. PubMed ID: 10590437
[TBL] [Abstract][Full Text] [Related]
18. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
Goto Y
Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
[No Abstract] [Full Text] [Related]
19. Deregulating mitochondrial metabolite and ion transport has beneficial effects in yeast and human cellular models for NARP syndrome.
Su X; Rak M; Tetaud E; Godard F; Sardin E; Bouhier M; Gombeau K; Caetano-Anollés D; Salin B; Chen H; di Rago JP; Tribouillard-Tanvier D
Hum Mol Genet; 2019 Nov; 28(22):3792-3804. PubMed ID: 31276579
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome.
Mäkelä-Bengs P; Suomalainen A; Majander A; Rapola J; Kalimo H; Nuutila A; Pihko H
Pediatr Res; 1995 May; 37(5):634-9. PubMed ID: 7603783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
